The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Chemotherapy-induced amenorrhea in premenopausal breast cancer patients treated with adjuvant anthracycline and taxane based chemotherapy within the SUCCESS study.
Julia Katharina Neugebauer
No relevant relationships to disclose
Brigitte Kathrin Rack
Research Funding - AstraZeneca; Chugai Pharma; Lilly; Novartis; Sanofi ; Veridex
Markus Kupka
No relevant relationships to disclose
Carina Dinkel
No relevant relationships to disclose
Bernadette Anna Sophia Jaeger
No relevant relationships to disclose
Uta Ortmann
No relevant relationships to disclose
Andreas Schneeweiss
No relevant relationships to disclose
Iris Schrader
No relevant relationships to disclose
Hans Tesch
No relevant relationships to disclose
Mahdi Rezai
No relevant relationships to disclose
Ulrike Soeling
No relevant relationships to disclose
Stefanie Noeding
No relevant relationships to disclose
Frauke Zabel
No relevant relationships to disclose
Harald Leo Sommer
Research Funding - AstraZeneca; Chugai Pharma; Lilly; Novartis; Sanofi ; Veridex
Klaus Friese
No relevant relationships to disclose
Matthias W. Beckmann
No relevant relationships to disclose
Wolfgang Janni
Research Funding - AstraZeneca; Chugai Pharma; Lilly; Novartis; Sanofi ; Veridex